When was PathAI founded?

PathAI was founded in 2016 and raised its 1st funding round 1 year after it was founded.

Where is PathAI located?

PathAI is headquartered in Boston, United States. It is registered at Cambridge, Massachusetts.

Who is the current CEO of PathAI?

Andrew H Beck of PathAI. They have also founded 1 company.

Which legal entities is PathAI associated with?

PathAI is associated with LYZR, INC. and 1 other.

How many employees does PathAI have?

As of Jul 31, 2026, the latest employee count at PathAI is 284.

Is PathAI a funded company?

PathAI is a funded company, having raised a total of $255M across 5 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Oct 18, 2017.

How much is PathAI worth?

The latest valuation of PathAI is $***** as of May 26, 2026.

When was the latest funding round of PathAI?

PathAI's latest funding was a $***** Series C round on May 18, 2021, with participation from 14 investors.

Where does PathAI rank among its competitors?

PathAI ranks 2nd amongst 280 active competitors, of which 82 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Techcyte, which secured $15M in Apr, 2026.

Who are the top competitors of PathAI?

PathAI's top competitors include PAIGE, Deciphex and Aignostics. Among them, Techcyte secured the most recent funding round in April, 2026.

PathAI - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of digital pathology image management system for clinical labs. It offers an AISight is a cloud-native intelligent enterprise workflow solution used by the laboratories and research centers to power their digital pathology workflows and AI applications. It serves as a central hub for case management, image management, and best-in-class artificial intelligence tools to enable multiple histopathology use cases.

Website: www.pathai.com
Social
Email ID: *****@pathai.com
Phone Number: +1 **********
Registered Address: Cambridge, Massachusetts

Key Metrics

Founded Year

2016

Location

Boston, United States

Stage

Series C

Total Funding

$255M in 5 rounds

Latest Funding Round

Series C, May 18, 2021, $*****

Post Money Valuation

$***** as on May 26, 2026

Investors

General Catalyst & 23 more

Ranked

2^nd among 280 active competitors

Employee Count

284 as on Jul 31, 2026

Investment & Acquisitions

Poplar Healthcare

Similar Companies

OpenEvidence & 2609 more

View PathAI's full profile

PathAI is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
LYZR, INC. CIN: 7631254 , United States, Active	Aug 18, 2023	-	-	-
Pathai, Inc. CIN: 811778508 , United States, Active	Dec 31, 2015	-	161 (As on Dec 31, 2024)	-

PathAI has raised a total funding of $255M over 5 rounds. Its first funding round was on Oct 18, 2017. Its latest funding round was a Series C round on May 18, 2021 for $*****. 14 investors participated in its latest round. PathAI has 24 institutional investors.

Here is the list of recent funding rounds of PathAI:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 18, 2021	4705020	Series C	6367003	5524442	4283531	1964407
Nov 04, 2019	7867066	Series B	6529641	7040828	8309598	1938385
Jul 24, 2019	7971952	Series B	1613717	8734418	LabCorp	9508124

Access funding benchmarks and valuations. Sign up today!

View details of PathAI's funding rounds and investors

The founders of PathAI are Aditya Khosla and Andrew H Beck. Andrew H Beck is the CEO of PathAI.

Here are the details of PathAI's key team members:

Aditya Khosla: Former Co-Founder of PathAI. They are also an angel investor in 1 startup and serve on the board of 1 company.
Andrew H Beck: Co-Founder & CEO of PathAI.
Contact Info: 1 email address

PathAI's Board of Directors

PathAI's board has 5 active members. Aditya Khosla, Andrew Beck, Stanley Lapidus, Michelle Dipp and JEFF LEIDEN are independent board members.

Here is the list of PathAI's board of directors:

Name	Type	Representing	Status	Duration
Aditya Khosla	Independent board member	-	Current	8y 9m
yebll{o	Independent board member	-	Current	2y 3m
qirbb{z	Independent board member	-	Current	4y 2m
vjku{kl	Independent board member	-	Current	7y 3m
cuiikww	Independent board member	-	Current	4y 4m

View details of PathAI's Founder profiles and Board Members

PathAI's employee count trend

PathAI has 284 employees as of Jul 26. Here is PathAI's employee count trend over the years:

Uncover PathAI's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of PathAI include PAIGE, Deciphex and Aignostics. Here is the list of Top 10 competitors of PathAI, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	PAIGE 2018, New York City (United States), Acquired	Developer of AI applications and foundation models for cancer diagnostics	$241M	Goldman Sachs, Casdin Capital & 9 others	71/100
2nd	PathAI 2016, Boston (United States), Series C	Provider of digital pathology image management system for clinical labs	$255M	Orbimed, Deep Learning & 22 others	71/100
3rd	Deciphex 2017, Dublin (Ireland), Series C	Network of pathologists providing digital diagnostic services for medical testing	$56.6M	Seroba Life Sciences, Molten Ventures & 13 others	65/100
4th	Aignostics 2018, Berlin (Germany), Series B	Developer of artificial intelligence software for biomedical image analysis applications	$53.9M	Boehringer Ingelheim Venture Fund, Wellington Partners Venture Capital ... & 9 others	64/100
5th	Aiforia 2014, Helsinki (Finland), Public	Provider of an AI and cloud-based, deep learning image analysis platform in all therapy areas	$23M	Ascend Capital Partners, Businessfinland & 8 others	64/100
6th	Nucle AI 2017, Chicago (United States), Series B	AI-assisted platform for image analysis	$60M	Vertex Ventures Israel, Sanofi Ventures & 9 others	62/100
7th	Techcyte 2014, Orem (United States), Series B	Artificial intelligence (AI) based image analysis platform for pathologists	$50.4M	ARUP Laboratories, Zoetis & 2 others	61/100
8th	Onc.ai 2020, San Carlos (United States), Series A	AI-based cancer treatment and diagnosis platform for healthcare providers	$31M	MassMutual, Accomplice & 12 others	61/100
9th	Visiopharm 2001, Horsholm (Denmark), Acquired	Developer of a SaaS and AI-based digital pathology solutions for image analysis and workflow standardization	$26.3M	BankInvest, Vaekstfonden & 4 others	60/100
10th	Enspectra Health 2014, Mountain View (United States), Series A	Developer of medical devices for tissue imagining and cancer detection	$15.5M	Foothill Ventures, Tao Capital Partners & 6 others	59/100